5 Amendments of Zbigniew ZIOBRO related to 2013/0305(COD)
Amendment 18 #
Proposal for a regulation
Recital 7
Recital 7
(7) The disparities between the varin the provisiouns governing restriction measures applied to news on the trade in psychoactive substances can also lead to displacement of harmful new psychoactive substances between the Member States, hampering efforts to restrict their availability to consumers and undermining consumer protection across the Unionsignificantly increase the risk of illegal smuggling channels arising for these substances and lead to laws being circumvented in order to obtain the necessary permits.
Amendment 22 #
Proposal for a regulation
Recital 10
Recital 10
Amendment 24 #
Proposal for a regulation
Recital 13
Recital 13
(13) Any Union action on new psychoactive substances should be based on scientific evidence, as well as on Member States’ wide experience in this area, and subject to a specific procedure. Based on the information notified by Member States, a report should be drawn up on new psychoactive substances that give rise to concerns across the Union. The report should indicate whether it is necessary to carry out a risk assessmentall include an assessment of the dangers posed by the relevant psychoactive substances. Following the risk assessment, the Commission should determine whether the new psychoactiveat restriction measures the relevant substances should be subjected to any restriction measures. In case of immediate public health concerns, the Commission should subject them to temporary consumer market restriction before the conclusion of the risk assessment. In case new information emerges on a new psychoactive substance, the Commission should re-assess the level of risks that it poses and re-impose market restrictions. Reports on new psychoactive substances should be made publicly available.
Amendment 27 #
Proposal for a regulation
Recital 18
Recital 18
Amendment 31 #
Proposal for a regulation
Recital 32
Recital 32
(32) The Commission should adopt immediately applicable implementing acts where, in duly justified cases relating to a rapid increase in the number of reported fatalities or incidents posing a grave threat to health in several Member States associated with the consumption of the new psychoactive substance concerned, imperative grounds of urgency so require.